profit from every $100 of sales.
$0$100
The Ensign Group
$186.19+0.59% today
+3.6% in 1 year
1-year low $147.131-year high $215.83
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $31.58 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What The Ensign Group sold, what it kept, and what it did with the cash.
Sales went from $3.03 billion in 2022 to $5.06 billion in 2025, with $344 million of profit last year.
SalesProfit
The Ensign Group handed back 10% of the cash it generated last year.
Buybacks $21M$14M
Free cash flow 2025$371M
Bought back its own shares$21M
Paid as dividends$14M
Cash vs. debt$504M vs. $2.2B
The Ensign Group vs. similar companies
The Ensign Group grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| The Ensign Group | 31.6× · Expensive | ||
 HCA Healthcare | 15.6× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.5× · Fair price | ||
 IHH Healthcare Berhad | 33.4× · Expensive | ||
 Rede D'Or São Luiz | 15.9× · Fair price |
Compare The Ensign Group with National HealthCare · PACS Group
AI analysis
An AI analyst reads The Ensign Group's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 2,403 | 2,627 | 3,025 | 3,729 | 4,260 | 5,058 | |
| – | – | 518 | 591 | 668 | 799 | |
| 223 | 260 | 297 | 255 | 358 | 425 | |
| 282 | 321 | 360 | 353 | 479 | 568 | |
| 170 | 195 | 225 | 209 | 298 | 344 | |
| 3.06 | 3.42 | 3.95 | 3.65 | 5.12 | 5.84 | |
| – | – | 17.1% | 15.8% | 15.7% | 15.8% | |
| 9.3% | 9.9% | 9.8% | 6.8% | 8.4% | 8.4% | |
| 7.1% | 7.4% | 7.4% | 5.6% | 7.0% | 6.8% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 2,546 | 2,851 | 3,452 | 4,178 | 4,669 | 5,463 |
| Cash | 237 | 262 | 316 | 510 | 465 | 504 |
| Total debt | 1,116 | 1,269 | 1,574 | 1,871 | 1,974 | 2,206 |
| Total liabilities | 1,727 | 1,829 | 2,203 | 2,680 | 2,829 | 3,228 |
| 818 | 1,021 | 1,247 | 1,492 | 1,837 | 2,232 | |
| 56 | 57 | 57 | 57 | 58 | 59 | |
| 9.3% | 9.1% | 8.3% | 6.6% | 8.2% | 8.3% | |
| 20.8% | 19.1% | 18.0% | 14.0% | 16.2% | 15.4% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 373 | 276 | 273 | 377 | 347 | 564 | |
| – | – | 88 | 106 | 158 | 194 | |
| – | – | 185 | 270 | 189 | 371 | |
| Dividends paid | 11 | 12 | 12 | 13 | 14 | 14 |
| 25 | 10 | 32 | 2 | 1 | 21 | |
| 15 | 19 | 23 | 31 | 36 | 48 |
Valuation
- 31.6×
- 24.7×
- 2.29
- 4.8×
- 2.1×
- 29.3×
- 22.1×
- 3.4%
- 3.2%
- 0.1%
Profitability
- 15.8%
- 8.4%
- 6.8%
- 11.3%
- 8.5%
- 8.0%
- 16.6%
- 6.5%
- 9.4%
- –
Growth
- +16.1%
- +13.8%
- +96.2%
- +4.5%
- +1.2%
Financial health
- 3.0×
- 0.99
- 40.0%
- 58.0×
- 1.42
- 1.56
- 0.94
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 36%of 958
Bottom 47%of 889
Bottom 41%of 601
Top 35%of 890
Top 33%of 987
What analysts expect
- Average price target
- $222.33
- Range
- $215.00 – $230.00
- 3 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 1.85 | 1.79 | +3.4% |
| Feb 4, 2026 | 1.82 | 1.75 | +4.0% |
| Nov 3, 2025 | 1.64 | 1.59 | +3.1% |
| Jul 24, 2025 | 1.59 | 1.55 | +2.6% |
| Apr 29, 2025 | 1.52 | 1.49 | +2.0% |
| Feb 5, 2025 | 1.49 | 1.47 | +1.4% |
| Oct 24, 2024 | 1.39 | 1.38 | +0.7% |
| Jul 25, 2024 | 1.32 | 1.30 | +1.5% |
0.1%of the share price, paid each year
On $1,000 invested$1a year at today's yield, before tax
+4.5%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$0.14 in 2015 → $0.25 in 2025
How safe it looks
4.2% of its profit
Room to growStretchedMore than it earns: 3.9%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
49No pass
Benjamin Graham
38No pass
Philip Fisher
43No pass
Peter Lynch
45No pass
Joel Greenblatt
12No pass
Charlie Munger
26No pass
Terry Smith
34No pass
Questions about The Ensign Group
Is The Ensign Group a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the The Ensign Group AI analysis
What does The Ensign Group do?
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. It is in Medical Care Facilities, based in San Juan Capistrano, CA, United States, with 46,000 employees.
Does The Ensign Group pay a dividend?
Yes. At today's price the dividend is 0.1% a year, about 4% of its yearly profit. In 2025 it paid out $14.4 million in dividends.
Is The Ensign Group stock halal?
Yes. The Ensign Group passes our halal screen: its business is permitted and its debt is 20% of its market value, under the 30% limit. How we check
How has The Ensign Group stock done over the past year?
Up 3.6% over the past twelve months, to $186.19. It traded between $147.13 and $215.83 and is 13.7% below its high.
Who are The Ensign Group's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with The Ensign Group's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.